Archives: Agenda

• Analyzing the efficiency and cost benefits of an all-in-one CRO versus using specialized CROs for different phases
• Evaluating the flexibility of a multi-CRO model in adapting to diverse project needs and expertise
• Weighing the risks of relying on a single provider versus the coordination challenges of managing multiple vendors
• Considering the impact on communication, data integration, and consistency when using a single CRO compared to multiple CROs
• Discussing the potential for innovation and quality improvements with specialized CROs versus the streamlined approach of an all-in-one model

Moderator

• Exploring how geopolitics influences clinical trials, from trade policies to international relations
• Discussing the impact of political changes and potential policy shifts
• Analyzing regulatory landscapes and incentives in alternative regions
• Addressing risk factors and strategic decision-making for trial site selection
• Examining the role of ERCs and strategy departments in navigating global shifts

• Identification of critical bottlenecks in multi-country biotech trials and practical methods to resolve them
• Optimisation of project management strategies to accelerate start-up and study conduct without compromising compliance and quality
• Enhancement of collaboration and leveraging of local expertise to ensure quality and timely delivery in European studies

• How AI optimizes clinical trial protocols to reduce errors, streamline processes, and enhance data quality
• A Real-world case study of reduced timelines and improved trial outcomes using Biorce’s platform
• Insights into leveraging predictive analytics for trial success

• Reducing recruitment timelines while improving enrollment success rates
• Integrating AI with electronic health records (EHR) and real-world data
• Overcoming ethical and regulatory challenges in AI-powered recruitment

TBD – Piotr Maślak